Traynor Capital Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-26,195
| Closed | -$2.93M | – | 226 |
|
|
2021
Q3 | $2.93M | Buy |
26,195
+11,248
| +75% | +$1.26M | 0.4% | 50 |
|
|
2021
Q2 | $2.33M | Buy |
14,947
+12,561
| +526% | +$1.96M | 0.33% | 57 |
|
|
2021
Q1 | $290K | Buy |
2,386
+31
| +1% | +$3.77K | 0.05% | 129 |
|
|
2020
Q4 | $360K | Buy |
2,355
+60
| +3% | +$9.17K | 0.06% | 109 |
|
|
2020
Q3 | $212K | Buy |
+2,295
| New | +$212K | 0.05% | 135 |
|
|
2019
Q4 | – | Sell |
-6,845
| Closed | -$280K | – | 174 |
|
|
2019
Q3 | $280K | Buy |
6,845
+375
| +6% | +$15.3K | 0.09% | 127 |
|
|
2019
Q2 | $308K | Buy |
+6,470
| New | +$308K | 0.1% | 123 |
|